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Volume 60, Number 1 Abstracts 265rates for up to 15 years. Screening was associated with more overall and
elective surgeries and fewer emergency operations and lower 30-day opera-
tive mortality rates at up to 10- to 15-years of follow-up. One RCT
involving 9342 women showed that screening had no beneﬁt on AAA
related mortality or all-cause mortality rates in women.
Comment: This updated review by the USPSTF reconﬁrms the value
of aneurysm screening in older males. The data remains limited by the fact
that the trials included for this evaluation consists mostly of white men
outside the United States and there’s little information about subgroups
and rescreening. Screening for abdominal aortic aneurysm thus far remains
the only vascular condition in which the USPSTF has found beneﬁt for the
screening process, with this group previously coming out against screening
for peripheral arterial disease and screening for carotid artery stenosis.
Optimizing the Outcome of Vascular Intervention for Takayasu’s
Arteritis
Perera AH, Youngstein T, Gibbs RGJ, et al. Br J Surg 2014;101:43-50.
Conclusions: Perioperative assessment in a detailed fashion will
improve vascular outcomes of Takayasu’s arteritis with focus on measure-
ment of disease activity and using optimal immunomodulatory therapy
before and after the procedure.
Summary: Takayasu’s arteritis (TA) is a large-vessel vascular arteritis
characterized by granulomatous changes of the aorta and its major branches.
The typical patient is under 40 years of age and the Takayasu’s process results
in stenotic or occlusive lesions predisposed to symptoms of end-organ
ischaemia such as claudication or hypertension. Less commonly there is
medial degeneration and aneurysmal dilation. There are numerous imaging
modalities including [18 F] ﬂuorodeoxyglucose combined positron emission
and computed tomography (18F-FDG-PET-CT), Doppler ultrasonography,
magnetic resonance angiography or CT angiography that have the ability to
identify prestenotic disease, and to reveal the extent of arterial injury and
perhaps to help monitor the response to immunomodulatory therapy (Ma-
son JC, Nat Rev Rheumatol 2010;6:406-415). Poor outcomes in patients
with Takayasu’s arteritis have been attributed to delayed diagnosis, which
may result from a lack of awareness of the condition, as well as late adminis-
tration of adequate medical treatment. Poor outcomes also can result from
inadequate patient selection and suboptimal timing of vascular intervention.
The authors sought to analyze, retrospectively, a cohort of patients with
Takayasu’s arteritis in the UK, to try to identify and analyze outcomes of
open surgical and endovascular interventions and to report concurrent use
of imaging before and after the procedure and also to investigate the impact
of perioperative immunosuppressive therapy. This was a retrospective view of
patients with Takayasu’s arteritis referred from 2001 and 2012 to a single ter-
tiary care center. 97 patients with Takayasu’s arteritis were seen. Immuno-
suppression was required in 87 patients (90%). Thirty-seven (38%)
underwent 64 procedures: 27 patients underwent 33 open surgical proce-
dures and 20 patients had 31 endovascular procedure. After a median
follow-up of 6 years, the overall success rate was 79% for open surgery
(mean graft patency, 9.4 years) and 52% for endovascular procedures (P ¼
.035). Procedural failure was reduced in patients receiving perioperative
immunosuppression, particularly in those with endovascular procedures (P
¼ .001). Clinical examination, measurement of acute-phase reactants and
combination non-invasive imaging including Doppler ultrasonography,
[18F] ﬂuorodeoxyglucose combined positron emission and computed to-
mography (CT), magnetic resonance angiography and CT angiography
were used to identify arterial lesions, establish the diagnosis and monitor
treatment outcomes. Overall and cumulative intervention failure rate was
34% (22 of 64), 7 (21%) of the 33 open and 15 (48%) of the 31 endovascular
procedures. Analyses of the outcomes of intervention suggested signiﬁcantly
improved results in those who received immunosuppression before an endo-
vascular intervention (P ¼ .001), but not necessarily for those that received
an open surgery (P ¼ .095). Six of the seven failed open procedures were
done in patients who did not receive preoperative medical therapy. 14 of
15 open procedures in patients who received medical therapy achieved
long-term patency (93%). In the endovascular group, 13 or the 15 failed pro-
cedures were not associated with preoperative immunomodulatory therapy.
However, 12 of 14 endovascular procedures associated with preoperative
immunomodulatory therapy remained patent.
Comment: In general, immunosuppression at the time of surgery is
considered a potential cause of postoperative complications. In this series,
however, no patient receiving immunosuppressive therapy at the time of
their procedure had a life-threatening complication and there were no dele-
terious effects of immunosuppressive therapy on surgical recovery or wound
infection noted. The data here would suggest that active suppression of the
Takayasu disease process at the time of therapy with immunosuppression
should be strongly considered with the beneﬁts of improved reconstruction
patency outweighing the adverse effects of the immunosuppression in the
perioperative period.Introduction of Surgical Safety Checklists in Ontario, Canada
Urbach DR, Govindarajan A, Saskin R, et al. N Engl J Med
2014;370:1029-38.
Conclusions: Implementation of surgical safety checklists in Ontario,
Canada did not result in signiﬁcant reductions of operative mortality or
complications.
Summary: In 2009, a study was published that suggested the imple-
mentation of a 19-item World Health Organization (WHO) Surgical Safety
Checklist substantially reduces the rate of surgical complications, from
11.0% to 7.0% in that study, and reduced the rate of in-hospital deaths
from 1.5% to 0.8% (Haynes AB et al, N Engl J Med 2009;360:491-9).
Largely as a direct result of that study surgical safety checklists were imple-
mented in thousands of hospitals world-wide in an effort to reduce in-hos-
pital complications and mortality. However, studies of the effects of
implementations of these checklists have been observational and limited
to small numbers of centers, and frequently have not evaluated patient out-
comes and have not showed the magnitude of effectiveness found in the
WHO study. Only studies including team training, and more comprehen-
sive safety systems that included multiple checklists have shown effectiveness
similar to those seen in the WHO study (Young-Xu Y et al, Arch Surg
2011;146:1368-73, and de Vries EN et al, N Engl J Med
2010;363:1928-37). In Ontario, Canada the Ministry of Health and
Long-Term Care mandated public reporting of adherence to surgical safety
checklists for hospitals beginning in July 2010. The authors felt this rapid
implementation of surgical safety checklists in Ontario was a natural exper-
iment to evaluate the effectiveness of checklist implementation at the pop-
ulation level in typical practice settings. They surveyed all acute care
hospitals in Ontario to determine when surgical safety checklists were adop-
ted. Using administrative health data they then compared operative mortal-
ity and rates of surgical complications linked to hospital stay and rates of
hospital readmission and urgent or emergency department visits within
30 days after discharge among patients undergoing a variety of surgical pro-
cedures, before and after adoption of the checklists. During the 3-month
period before and after adoption of the surgical safety checklists a total of
101 hospitals performed 109,341 and 106,370 procedures, respectively.
Adjusted risk of death during a hospital stay within 30 days after surgery
was 0.71% (95% CI, 0.66-0.76) before implementation of a surgical check-
list and 0.65% (95% CI, 0.60-0.70) afterward (odds ratio, 0.91; 95% CI,
0.80-1.03; P ¼ .13). Adjusted risk of surgical complications was 3.86%
(95% CI, 3.76-3.96) before implementation and 3.82% (95% CI, 3.71-
3.92) afterward (odds ratio, 0.97; 95% CI, 0.90-1.03; P ¼ .29).
Comment: The absence of effect of checklist implementation in this
study may reﬂect many possibilities. Perhaps published evidence on the ef-
ﬁcacy of implementing checklists within hospitals that participate in safety
research is not generalizable to all hospitals. Surgical safety checklists may
also be less effective in practice than suggested by existing literature.
Perhaps, as the authors point out, there is a Hawthorne Effect with a ten-
dency to perform better when work is under scrutiny that may explain the
strong effect of surgical safety checklists in studies in which hospitals where
workers were aware of the intervention under study. There may also be pub-
lication bias in that hospital based studies showing improvements in out-
comes after checklist implementation are more likely to be published than
negative studies. Also, as noted above, there may also be a greater effect
of surgical safety checklists when intensive team training is utilized along
with implementation of the checklists, and where there is better monitoring
compliance. Nevertheless, it does appear that the effectiveness of surgical
safety checklists, which have never been evaluated in a randomized control
trial, perhaps should undergo greater scrutiny.
Mortality From Ruptured Abdominal Aortic Aneurysms: Clinical
Lessons From a Comparison of Outcomes in England and the USA
Karthikesalingam A, Holt PJ, Vidal-Diez A, et al. Lancet 2014;383:963-9.
Conclusions: In-hospital survival from ruptured abdominal aortic
aneurysm (rAAA), intervention rates, and use of endovascular repair are
lower in England than in the USA. In England and the USA, lowest mor-
tality for rAAA is seen in teaching hospitals with larger bed capacities and
doing a greater proportion of cases with endovascular repair.
Summary: Outcomes of patients with rAAA vary by country. There
are likely modiﬁable technical, organizational and hospital related factors
that play important roles in patient care and outcomes of rAAA. Such vari-
ables merit further study to help optimize service delivery and improve pa-
tient outcomes for care of what is otherwise a fatal disease. In this paper, the
authors compare data from the Hospital Episode Statistics for England and
the Nationwide Inpatient Sample for the USA for patients admitted to hos-
pital with rAAA from 2005 to 2010. Primary outcomes were in-hospital
mortality, mortality after intervention, and decision to follow noncorrective
treatment. In-hospital mortality and the rates of non-corrective treatment
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adjustment for age, sex, year, and Charlston comorbidity index. The study
included 11,799 patients with rAAA in England and 23,838 patients with
rAAA in the USA. In-hospital mortality was lower in the USA than in En-
gland (53.05% [95% CI, 51.26-54.85] vs 65.9%; P < .0001). Intervention
(open or endovascular repair) was offered to a greater proportion of cases in
the USA than in England (19,174 [80.43%] vs 6897 [58.45%]; P < .0001).
Endovascular repair was more common in the USA than in England (4003
[20.88%] vs 589 [8.54%]; P < .0001). Postintervention mortality was
similar in both countries (41.77% for England and 41.65% for USA). Obser-
vations were no different in age-matched and sex-matched comparisons. In
both countries reduced mortality was associated with increased use of endo-
vascular repair, increased hospital caseload (volume) for rAAA, high hospital
bed capacity, hospitals with teaching status, and admission on a weekday.
Comment: The data demonstrate that in-hospital mortality for pa-
tients with rAAA is lower in the USA than England with the difference
mainly attributed to the fact that in the U.S. patients were less likely to
be managed by non-corrective measures and aneurysm repair was offered
for a greater proportion of patients with rAAA. Even though endovascular
repair was more common in the USA, overall operative mortality was similar
in the two countries. In both countries, outcomes are better in hospitals
with larger volumes, teaching hospitals, and when patients are admitted dur-
ing regular working hours. It is unclear if these are independent correlates or
whether hospital capacity, teaching status and admission on a week day as
well as rAAA caseload are all basically interrelated surrogate markers for
the immediacy with which patients with rAAA have access to a full range
of technology and care by a specialized multi-disciplinary team. However,
the authors conclude that “service conﬁguration should focus on insuring
that patients with rAAA are treated in a teaching hospital with a high aortic
workload, offering both conventional and endovascular repair”.
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt DL, Kandzari DE, O’Neill WW, and the SYMPLICITY HTN-3
Investigators, et al. N Engl J Med 2014;370:1393-401.
Conclusions: Six months following renal-artery denervation in pa-
tients with resistant hypertension there is no signiﬁcant reduction of systolic
blood pressure.
Summary: Resistant hypertension is deﬁned as a systolic blood pres-
sure of $140 mm Hg despite adherence to at least three maximally toler-
ated doses of antihypertensive medications from complimentary classes,
including a diuretic at an appropriate dose (Smith SM et al, J Hypertens
2013; 32:635-43). Approximately 10% of patients with hypertension have
resistant hypertension. Cross-talk between the kidneys and the brain medi-
ated by the sympathetic nervous system appears to play an important role in
resistant hypertension (Bakris G et al, J Am Coll Cardiol 2013 November
25 [Epub ahead of print]). Recently, catheter-based radiofrequency dener-
vation of the renal arteries has emerged as a potential treatment for resistant
hypertension and is already in clinical use in more than 80 countries
including parts of Europe, South America, Australia, and Canada. Initial
nonrandomized studies and randomized, unblinded trials have shown sig-
niﬁcant reductions in blood pressure, as measured at ofﬁce visits, after renal
denervation (Krum H et al, Lancet 2009; 373:1275-81). However, initial
studies have included small sample sizes, and limited assessment of ambula-
tory blood pressure, and had not utilized blinding, or a sham procedures.
These drawbacks have limited broad application of the ﬁndings as poten-
tially unreliable. In this trial the authors performed a prospective, single-
blind, randomized, sham-controlled trial, to try and overcome many of
the previous methodology limitations of previous smaller studies. Patients
with severe resistant hypertension were randomly assigned in a 2 to 1 ratio
to undergo renal-denervation or a sham procedure. Prior to randomization
patients received a stable antihypertensive regimen involving maximally
tolerated doses of at least three drugs, including a diuretic. The primary ef-
ﬁcacy end point of the trial was the change in ofﬁce systolic blood pressure
at 6 months; a secondary efﬁcacy end point was the change in mean 24-hour
ambulatory systolic blood pressure. The primary safety end point was a com-
posite of death, end-stage renal disease, embolic events resulting in end-or-
gan damage, renovascular complications, or hypertensive crisis at 1 month
or new renal-artery stenosis of more than 70% at 6 months. There were a
total of 535 patients who underwent randomization. The mean (6SD)
change in systolic blood pressure at 6 months was 14.13 6 23.93 mm
Hg in the denervation group as compared with 11.74 6 25.94 mm Hgin the sham-procedure group (P < .001 for both comparisons of the change
from baseline), for a difference of 2.39 mm Hg (95% CI, 6.89 to 2.12; P
¼ .26 for superiority with a margin of 5 mm Hg). The change in 24-hour
ambulatory systolic blood pressure was 6.75 6 15.11 mm Hg in the
denervation group and 4.79 6 17.25 mm Hg in the sham-procedure
group, for a difference of 1.96 mm Hg (95% CI, 4.97 to 1.06; P ¼
.98 for superiority with a margin of 2 mm Hg). There were no signiﬁcant
safety differences between the two groups.
Comment: These ﬁndings contradict previously published clinical
data regarding renal denervation which showed large reductions in blood
pressure 6 months after denervation, and in the unblinded SIMPLICITY
HTN-2 Trial. Clearly it is important to conduct blinded trials with sham
controls in the evaluation of new medical devices before clinical adoption
of these devices occurs. Prior unblinded randomized trials may represent a
placebo effect as a treatment effect. Indeed, a placebo effect was demon-
strated in this trial with the sham procedure. While there was no direct mea-
surement to conﬁrm renal nerves were in fact de-enervated by the
SIMPLICITY catheter system, at this point it does not appear that there
is sufﬁcient evidence to promote wide spread adoption of renal denervation
in the treatment of resistant hypertension.
Safety and Feasibility of a Diagnostic Algorithm Combining Clinical
Probability, D-Dimer Testing, and Ultrasonography for Suspected
Upper Extremity Deep Venous Thrombosis: A Prospective
Management Study
Kleinjan A, Di Nisio M, Beyer-Westendorf J, et al. Ann Intern Med
2014;160:451-7.
Conclusions: A combination of D-dimer testing and clinical probabil-
ity assessment can improve the efﬁciency of diagnosis of upper extremity
DVT.
Summary: There are diagnostic algorithms combining clinical proba-
bility assessment, D-dimer testing, and ultrasonography that are widely
advocated for suspected DVT of the leg (Gibson NS et al, J Thromb Hae-
most 2009;7:2035-41). In patients with suspected UEDVT, D-dimer has
been evaluated as contributing to the diagnosis in only one series of 52
consecutive patients (Merminod T et al, Blood Coagul Fibrinolysis
2006;17:225-6). Clinical probability has been evaluated in patients with
UEDVT and the conﬁrmed incidence of UEDVT has been about 12%,
20%, and 70% in patients with low, intermediate and high clinical probability
of UEDVT (Constans J et al, Thromb Haemost 2008:99:202-7). However,
a combination of D-dimer testing and clinical probability has not been eval-
uated in patients with possible UEDVT and such an algorithm, if effective,
would be useful in that the large majority of patients evaluated for UEDVT
with ultrasonography alone, do not have the condition. The purpose of this
study was to test the safety and feasibility of a diagnostic algorithm in pa-
tients with clinically suspected UEDVT. The study took place in 16 hospi-
tals in Europe and the United States and consisted of 406 inpatients and
outpatients with suspected UEDVT. The diagnostic algorithm consisted
of sequential applications of a clinical decision score, Constans clinical deci-
sion score, that incorporated presence of localized pain, unilateral edema,
and the possibility of any other diagnosis, as well as D-dimer testing and ul-
trasonography. Patients were classiﬁed as likely or unlikely to have UEDVT.
In those with an unlikely score and normal D-dimer levels UEDVT was
considered excluded. All other patients had (repeated) compression ultraso-
nography to evaluate for UEDVT. The primary outcome was the 3-month
incidence of symptomatic UEDVT and pulmonary embolism in patients
with a normal diagnostic work-up. In 390 of the 406 patients (96%) the al-
gorithm was feasible and completed. In 87 patients (21%), an unlikely score
combined with normal D-dimer levels to exclude UEDVT. Superﬁcial
venous thrombosis and UEDVT were diagnosed in 54 (13%) and 103
(25%) patients, respectively. There were 249 patients with a normal diag-
nostic work-up including those with protocol violations who were then fol-
lowed for 3 months. One patient developed UEDVT during follow-up, for
an overall failure rate of the diagnostic algorithm of 0.4% (95% CI, 0.0%-
2.2%).
Comment: Although the study was not powered to show the safety of
various sub-strategies to exclude UEDVT, such as the Constans score alone
or D-dimer levels alone; if conﬁrmed by other studies, the algorithm pre-
sented would appear to have the potential to improve the efﬁciency of diag-
nosis of upper extremity DVT by eliminating the use of a large number of
ultrasound studies ultimately proving to be negative.
